These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7687444

  • 1. Transdermal dihydrotestosterone treatment of 'andropause'.
    de Lignieres B.
    Ann Med; 1993 Jun; 25(3):235-41. PubMed ID: 7687444
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.
    Mårin P, Krotkiewski M, Björntorp P.
    Eur J Med; 1992 Oct; 1(6):329-36. PubMed ID: 1341460
    [Abstract] [Full Text] [Related]

  • 4. Prolactin influences upon androgen action in male accessory sex organs.
    Thomas JA, Keenan EJ.
    Adv Sex Horm Res; 1976 Oct; 2():425-70. PubMed ID: 189591
    [Abstract] [Full Text] [Related]

  • 5. The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study.
    Kunelius P, Lukkarinen O, Hannuksela ML, Itkonen O, Tapanainen JS.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1467-72. PubMed ID: 11932266
    [Abstract] [Full Text] [Related]

  • 6. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R, Hahn RG, Ray P, Shannon JB, Wurzel R.
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [Abstract] [Full Text] [Related]

  • 7. Influence of radical prostatectomy on serum hormone levels.
    Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC.
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
    Idan A, Griffiths KA, Harwood DT, Seibel MJ, Turner L, Conway AJ, Handelsman DJ.
    Ann Intern Med; 2010 Nov 16; 153(10):621-32. PubMed ID: 21079217
    [Abstract] [Full Text] [Related]

  • 9. Estradiol and high-dose dihydrotestosterone treatment causes changes in cynomolgus monkey prostate volume and histology identical to those caused by testosterone alone.
    Kamischke A, Weinbauer GF, Semjonow A, Lerchl A, Richter KD, Nieschlag E.
    J Androl; 1999 Nov 16; 20(5):601-10. PubMed ID: 10520572
    [Abstract] [Full Text] [Related]

  • 10. Effects of long-term administration of androgens and estrogen on rhesus monkey prostate: possible induction of benign prostatic hyperplasia.
    Jeyaraj DA, Udayakumar TS, Rajalakshmi M, Pal PC, Sharma RS.
    J Androl; 2000 Nov 16; 21(6):833-41. PubMed ID: 11105909
    [Abstract] [Full Text] [Related]

  • 11. Androgen and prostatic stroma.
    Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, Sun G.
    Asian J Androl; 2003 Mar 16; 5(1):19-26. PubMed ID: 12646998
    [Abstract] [Full Text] [Related]

  • 12. Decline of serum levels of free testosterone in aging healthy Chinese men.
    Li JY, Li XY, Li M, Zhang GK, Ma FL, Liu ZM, Zhang NY, Meng P.
    Aging Male; 2005 Mar 16; 8(3-4):203-6. PubMed ID: 16390747
    [Abstract] [Full Text] [Related]

  • 13. Decline of plasma 5alpha-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels.
    Gooren LJ, Saad F, Haide A, Yassin A.
    Andrologia; 2008 Oct 16; 40(5):298-302. PubMed ID: 18811920
    [Abstract] [Full Text] [Related]

  • 14. Hormone regulation of human prostate in organ culture.
    Nevalainen MT, Härkönen PL, Valve EM, Ping W, Nurmi M, Martikainen PM.
    Cancer Res; 1993 Nov 01; 53(21):5199-207. PubMed ID: 7693334
    [Abstract] [Full Text] [Related]

  • 15. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
    Yatkin E, Bernoulli J, Talvitie EM, Santti R.
    Int J Androl; 2009 Aug 01; 32(4):399-410. PubMed ID: 19515173
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of dihydrotestosterone remain in the normal range in men treated with long-acting parenteral testosterone undecanoate.
    Yassin AA, Saad F.
    Andrologia; 2007 Oct 01; 39(5):181-4. PubMed ID: 17714216
    [Abstract] [Full Text] [Related]

  • 17. Impact level of dihydrotestosterone on the hypothalamic-pituitary-leydig cell axis in men.
    Cailleux-Bounacer A, Rohmer V, Lahlou N, Lefebvre H, Roger M, Kuhn JM.
    Int J Androl; 2009 Feb 01; 32(1):57-65. PubMed ID: 17931384
    [Abstract] [Full Text] [Related]

  • 18. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
    Wurzel R, Ray P, Major-Walker K, Shannon J, Rittmaster R.
    Prostate Cancer Prostatic Dis; 2007 Feb 01; 10(2):149-54. PubMed ID: 17189955
    [Abstract] [Full Text] [Related]

  • 19. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y, Ye L, Ding Q, Fang Z, Yao M, Shi D.
    Zhonghua Wai Ke Za Zhi; 2000 Jul 01; 38(7):545-7. PubMed ID: 11832106
    [Abstract] [Full Text] [Related]

  • 20. Serum androgen bioactivity during 5alpha-dihydrotestosterone treatment in elderly men.
    Raivio T, Tapanainen JS, Kunelius P, Jänne OA.
    J Androl; 2002 Jul 01; 23(6):919-21. PubMed ID: 12399539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.